Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NVP-BSK805 2HCl (1092499-93-8(free base)) (BSK 805) 是一种特异性有效的 ATP 竞争性 JAK2 抑制剂,其特异性是 JAK1、JAK3 和 TYK2 的 20 倍以上。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 511 | 现货 | ||
2 mg | ¥ 917 | 现货 | ||
5 mg | ¥ 1,730 | 现货 | ||
10 mg | ¥ 2,380 | 现货 | ||
25 mg | ¥ 3,950 | 现货 | ||
50 mg | ¥ 5,750 | 现货 | ||
100 mg | ¥ 7,850 | 现货 | ||
500 mg | ¥ 15,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,910 | 现货 |
产品描述 | NVP-BSK805 2HCl (1092499-93-8(free base)) (BSK 805)(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2. |
靶点活性 | JAK2:0.5 nM |
体外活性 | NVP-BSK805 is found to potently inhibit JAK2, whereas displaying more than 20-fold selectivity towards JAK1, JAK3, and TYK2. NVP-BSK805 causes half-maximal inhibition of full-length JAK2V617F and JAK2 wild-type enzymes at 0.5 nM. NVP-BSK805 blocks the growth of JAK2V617F cells (Ba/F3) and induces apoptosis with a GI50 at concentrations <100 nM. As constitutive STAT5 phosphorylation in dependent on JAK2, NVP-BSK805 is found to potently suppress STAT5 phophorylation at ≥ 100 nM concentrations in the JAK2 V617F -mutant cell lines, like MB-02. Incubation of SET-2 cells with 150 nM and 1 μM of NVP-BSK805, which corresponds to concentration yielding 75% and 95% growth inhibition, respectively, for 24, 48, and 72 hours lead to concentration- and time- dependent induction of apoptosis. These results are evidenced by the detection of cleaved PARP, reduced Bcl-xL expression, and a strong increase in the number of cells with less than 2N DNA content. [1] NVP-BSK805 triggered cell death requires activation of caspase cascades and is overcome by caspase inhibition in both SET-2 and MB-02 cells. NVP-BSK805 modulates the post-translational modification of Bim and levels of Mcl-1 in JAK2V617F cells, SET-2 and MB-02 cells. [2] |
体内活性 | Oral bioavailability of NVP-BSK805 in mice is estimated to be 45%, while it is 50% in rats. Oral administration of NVP-BSK805 at 150 mg/kg suppresses STAT5 phosphorylation, splenomegaly, and leukemic cell spreading in a Ba/F3 JAK2V617F cell–driven mouse model. NVP-BSK805 suppresses rhEpo-induced STAT5 phosphorylation as well as rhEpo-mediated polycythemia and splenomegaly in BALB/c mice at doses of 25, 50, and 100 mg/kg orally. [1] |
细胞实验 | The anti-proliferative activity of JAK2 inhibitors is determined by incubating cells for 72 hours with an 8-point concentration range of compound and cell proliferation relative to DMSO-treated cells is measured using the colorimetric WST-1 (Roche Diagnostics GmbH) cell viability readout. Of each triplicate treatment, the mean is calculated and these data are plotted in XLfit 4 (ID Business Solutions, Ltd.) to determine the half-maximal growth inhibition (GI50) values.(Only for Reference) |
别名 | NVP-BSK805 dihydrochloride, BSK 805, NVP-BSK805 (dihydrochloride) |
分子量 | 563.47 |
分子式 | C27H28F2N6O·2HCl |
CAS No. | T6294 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 3 mg/mL (5.32 mM)
DMSO: 113 mg/mL (200.54 mM)
Ethanol: 15 mg/mL (26.62 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO / Ethanol | 1 mM | 1.7747 mL | 8.8736 mL | 17.7472 mL | 44.3679 mL |
5 mM | 0.3549 mL | 1.7747 mL | 3.5494 mL | 8.8736 mL | |
DMSO / Ethanol | 10 mM | 0.1775 mL | 0.8874 mL | 1.7747 mL | 4.4368 mL |
20 mM | 0.0887 mL | 0.4437 mL | 0.8874 mL | 2.2184 mL | |
DMSO | 50 mM | 0.0355 mL | 0.1775 mL | 0.3549 mL | 0.8874 mL |
100 mM | 0.0177 mL | 0.0887 mL | 0.1775 mL | 0.4437 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NVP-BSK805 2HCl (1092499-93-8(free base)) T6294 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK NVP-BSK805 dihydrochloride NVP-BSK-805 Dihydrochloride BSK 805 NVP BSK805 2HCl (1092499 93 8(free base)) BSK805 盐酸NVP-BSK805 NVP-BSK-805 NVPBSK805 2HCl (1092499938(free base)) NVP-BSK805 (dihydrochloride) NVP-BSK 805 Dihydrochloride NVP-BSK 805 NVP-BSK805 Dihydrochloride NVP-BSK805 2HCl (1092499-93-8 free base) NVP-BSK805 BSK-805 NVP-BSK-805 2HCl (1092499-93-8(free base)) Inhibitor inhibitor inhibit